|
|
Article Cited by others RESEARCH ARTICLE
The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial
Abidi Afroz, Rizvi Dilshad Ali, Saxena Kshitij, Chaudhary Savita, Ahmad Ali
Year : 2020| Volume: 52| Issue : 1 | Page no: 16-22 This article has been cited by | 1 |
Effects of Hypolipidemic Drugs on Psoriasis |
|
| | Mateusz Matwiejuk, Hanna Mysliwiec, Olivia Jakubowicz-Zalewska, Adrian Chabowski, Iwona Flisiak | | | Metabolites. 2023; 13(4): 493 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
The Role of Transcription Factor PPAR-? in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells |
|
| | Vladimir V. Sobolev, Ekaterina Tchepourina, Irina M. Korsunskaya, Natalia A. Geppe, Svetlana N. Chebysheva, Anna G. Soboleva, Alexandre Mezentsev | | | International Journal of Molecular Sciences. 2022; 23(17): 9708 | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Peroxisome proliferator-activator receptor ? and psoriasis, molecular and cellular biochemistry |
|
| | Xiran Lin, Xianmin Meng, Zhiqi Song, Jingrong Lin | | | Molecular and Cellular Biochemistry. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Methotrexate Dosing Regimen for Plaque-type Psoriasis: An Update of a Systematic Review |
|
| | Astrid M. van Huizen, Rosie Sikkel, Anouk G.M. Caron, Stef P. Menting, Phyllis I. Spuls | | | Journal of Dermatological Treatment. 2022; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | 5 |
Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier |
|
| | Arya K. Ramanunny, Sheetu Wadhwa, Divya Thakur, Sachin K. Singh, Rajesh Kumar | | | Endocrine, Metabolic & Immune Disorders - Drug Targets. 2021; 21(3): 418 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|